Drug reference
sulfonylurea hypoglycaemics
ATP-sensitive K+ channel inhibitor · Hypoglycaemic agent
ATP-sensitive K+ channel inhibitorHypoglycaemic agent
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Inhibit pancreatic ATP-sensitive K+ channels.
Related guidelines
Ask House about sulfonylurea hypoglycaemics
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team